
New study finds bortezomib improves survival in children with newly diagnosed T-cell lymphoblastic lymphoma
Adding the proteasome inhibitor bortezomib to chemotherapy significantly improved overall survival in children and young adults with newly diagnosed T-cell lymphoblastic lymphoma (T-LL), according to a Children's Oncology ...
Mar 10, 2022
0
63